Anesthesiology, Pain Medicine · Evansville, IN
NPI
1750522660
Since 2009
Specialty
Anesthesiology, Pain Medicine
Code 207LP2900X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
700 Kimber Lane
Evansville, IN, 47715
Phone (812) 476-7111
Groups this clinician bills Medicare through
Medicare paid, 2024
$769K
15,143 services
Medicare patients, 2024
928
Average age 70
Drug cost, 2024
$163K
3,677 prescriptions
Company payments, 2025
$644
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Nicolaus D Winters was code J3301 (injection, triamcinolone acetonide, not otherwise specified, 10 mg), 7,103 times for 501 patients. In total Nicolaus D Winters billed 15,143 services in 78 codes, and Medicare paid $769K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-09-04.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 7,103 | 501 | $0.74 | $5,275 |
| 99214 Office E&M - Established | Office | 713 | 429 | $86.91 | $62K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 637 | 402 | $12.49 | $7,958 |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 470 | 93 | $46.09 | $22K |
| 64483 Nerve Block Injection - Back | Office | 286 | 189 | $221.43 | $63K |
| 99213 Office E&M - Established | Office | 278 | 215 | $60.67 | $17K |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 244 | 68 | $35.58 | $8,682 |
| 27096 Joint Injection | Office | 227 | 164 | $139.24 | $32K |
| 77002 Imaging - Miscellaneous | Office | 222 | 113 | $75.22 | $17K |
| 64635 Destruction by Neurolytic Agent - Back | Office | 176 | 138 | $445.40 | $78K |
| 20610 Joint Injection | Office | 173 | 90 | $52.44 | $9,072 |
| 64636 Destruction by Neurolytic Agent - Back | Office | 169 | 132 | $243.81 | $41K |
| 64493 Nerve Block Injection - Back | Office | 158 | 93 | $178.11 | $28K |
| 64494 Nerve Block Injection - Back | Office | 155 | 91 | $96.55 | $15K |
| 80307 Drug Tests | Office | 105 | 105 | $60.37 | $6,339 |
By year: 2022 $795K for 13,383 services; 2023 $736K for 13,113 services; 2024 $769K for 15,143 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 80307 Drug Tests | 105 | 105 | $60.37 | $6,339 |
| G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 27 | 27 | $233.82 | $6,313 |
| G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 20 | 20 | $153.46 | $3,069 |
Medicare prescription drug claims, 2024
In 2024, the drug Nicolaus D Winters prescribed most often to Medicare patients was Oxycodone-Acetaminophen (Oxycodone Hcl/Acetaminophen), with 1,361 prescriptions and refills. In total Nicolaus D Winters wrote 3,677 Medicare prescriptions that cost $163K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 1,361 | 1,362 | 412 | $41K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 900 | 900 | 471 | $20K |
| Gabapentin Generic | 345 | 383 | 232 | $4,374 |
| Pregabalin Generic | 155 | 162 | 107 | $3,318 |
| Oxycodone Hcl Generic | 144 | 144 | 49 | $3,486 |
| Tramadol Hcl Generic | 102 | 102 | 72 | $415 |
| Morphine Sulfate Er Morphine Sulfate | 66 | 66 | 25 | $2,116 |
| Buprenorphine Generic | 61 | 61 | 42 | $19K |
| Hydromorphone Hcl Generic | 54 | 54 | 20 | $803 |
| Tizanidine Hcl Generic | 46 | 62 | 27 | $532 |
| Belbuca Buprenorphine Hcl | 43 | 43 | 29 | $24K |
| Fentanyl Generic | 40 | 40 | 11 | $6,141 |
| Pentazocine-Naloxone Hcl Pentazocine Hcl/Naloxone Hcl | 33 | 33 | 13 | $4,271 |
| Amantadine Amantadine Hcl | 27 | 27 | 11 | $3,600 |
| Meloxicam Generic | 25 | 25 | 17 | $684 |
Brand drugs: 132 claims; generic drugs: 3,545 claims; opioid claims: 2,855.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Nicolaus D Winters $644 ($644 in general payments such as food, travel and fees) from 6 companies. The largest payer was Abbott Laboratories with $479.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.